Cholangiocarcinoma: recent progress. Part 2: molecular pathology and treatment (Q34803024)

4 August 2017

1 reference

title

Cholangiocarcinoma: recent progress. Part 2: molecular pathology and treatment (English)

1 reference

4 August 2017

0 references

0 references

Kunio Okuda

1

1 reference

4 August 2017

Yasuni Nakanuma

series ordinal

2

1 reference

4 August 2017

Masaru Miyazaki

series ordinal

3

1 reference

4 August 2017

language of work or name

1 reference

1 October 2002

1 reference

Journal of Gastroenterology and Hepatology

4 August 2017

1 reference

4 August 2017

17

1 reference

4 August 2017

10

1 reference

4 August 2017

1056-1063

1 reference

Ki-ras mutations and p53 protein expressions in intrahepatic cholangiocarcinomas: relation to gross tumor morphology.

4 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02780.X

Bcl-2 is overexpressed and alters the threshold for apoptosis in a cholangiocarcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02780.X

Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02780.X

Fas-induced caspase denitrosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02780.X

Overexpression of C-NEU and C-MET during rat liver cholangiocarcinogenesis: A link between biliary intestinal metaplasia and mucin-producing cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02780.X

Immunohistochemical demonstration of MET overexpression in human intrahepatic cholangiocarcinoma and in hepatolithiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02780.X

Histological features and interphase nucleolar organizer regions in hyperplastic, dysplastic and neoplastic epithelium of intrahepatic bile ducts in hepatolithiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02780.X

Relationship between interleukin-6 and proliferation and differentiation in cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02780.X

Unique epithelial cell production of hepatocyte growth factor/scatter factor by putative precancerous intestinal metaplasias and associated "intestinal-type" biliary cancer chemically induced in rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02780.X

p53 but not bcl-2 is expressed by most cholangiocarcinomas: a study of 28 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02780.X

Transforming growth factor-beta 1 stimulates or inhibits cell growth via down- or up-regulation of p21/Waf1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02780.X

Cholangiocarcinomas in Japanese and Thai patients: difference in etiology and incidence of point mutation of the c-Ki-ras proto-oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02780.X

Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02780.X

Expression of inducible nitric oxide synthase in human granulomas and histiocytic reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02780.X

Carcinoembryonic antigen and blood group-related carbohydrate antigens in glycoproteins in human bile in hepatolithiasis. Japanese Study Group of Hepatolithiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02780.X

Access to peptide regions of a surface mucin (MUC1) is reduced by sialic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02780.X

Biphasic effect of cell surface sialic acids on pancreatic cancer cell adhesiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02780.X

Photodynamic therapy of nonresectable cholangiocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02780.X

Surgical management of intrahepatic cholangiocarcinoma: a 31-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02780.X

Allelic loss in human intrahepatic cholangiocarcinoma: correlation between chromosome 8p22 and tumor progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02780.X

Hepatic resection and transplantation for peripheral cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02780.X

Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02780.X

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2002.02780.X

10.1046/J.1440-1746.2002.02780.X

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference